2型糖尿病患者血尿酸水平和尿白蛋白排泄量的相关性研究
被引量:4
摘要
糖尿病导致的慢性肾脏疾病(chronic kidney disease,CKD)在逐年增加,在美国,43%的糖尿病患者出现微量白蛋白尿,8%的糖尿病患者可见大量白蛋白尿[1]。
出处
《浙江医学》
CAS
2011年第10期1536-1538,共3页
Zhejiang Medical Journal
参考文献13
-
1National Kidney Foundation.K/DOQ I clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39 (S1):S1-S266.
-
2Klein R,Klein B E,Moss S E,et al.Ten-year incidence of gross proteinuria in people with diabetes.Diabetes[J] ,1995,44:916-923.
-
3Tseng C H.Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan[J].Kidney international,2005,68:796-801.
-
4Michiali Fukui,Muhei Tanaka,Emi Shiraishi,et al.Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus[J].Metabolism Clinical and Exprimental,2008,57:625-629.
-
5Mogensen C E.Microalbuminuria as a predictor of clinical diabetic nephropathy.Kidney Int[J] ,1987,31:673-684.
-
6Niskanen L K,Laaksonen D E,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J].Arch Intern Med,2004,164:1546-1551.
-
7Milionis H J,Kalantzi K J,Goudevenos J A,et al.Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects[J].J Intern Med,2005,258:435-541.
-
8Tomita M,Mizuno S,Yamanaka H,et al.Does hyperuricemia affect mortality?A prospective cohort study of Japanese male workers[J].J Epidemiol,2000,10:403-409.
-
9Wu A Y,Tan C B,Eng P H,et al.Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes mellitus in Singapore[J].SingaporeMed J,2006,47 (4):315-320.
-
10Coutinho Tde A,Turner ST,Peyser PA,et al.Associations of serum uric acid with markers of in?ammation,metabolic syndrome,and subclinical coronary atherosclerosis[J].Am J Hypertens,2007,20:83-89.
同被引文献61
-
1胡仁明.糖尿病肾脏病变的诊断和治疗[J].中国医学前沿杂志(电子版),2012,4(3):36-38. 被引量:5
-
2管乐,郑少雄.2型糖尿病肾病危险因素[J].中华肾脏病杂志,2006,22(1):18-18. 被引量:12
-
3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
-
4Collins AJ, Foley RN, Herzog C, et al. United States Renal Data Sys- tem 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis, 2012, 59(1 Suppl 1): 1-420.
-
5Levin A, Rocco M. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am JKidney Dis, 2007, 49(2 Suppl 2): S12-154.
-
6Gowdak LH, Arantes RL, Paula FJ, et al. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients. Ren Fail, 2007, 29(5): 559-565.
-
7Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting out- comes in patients with type 2 diabetes and nephropathy: the RE- NAAL study. Clin J Am Soc Nephrol, 2006, 1(4): 761-767.
-
8Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med, 2010, 268(5):456-467.
-
9Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy. Contrib Nephrol, 2011, 170: 1-7.
-
10Tang SC. Diabetic nephropathy: a global and growing threat. Hong Kong Med J, 2010, 16(4): 244-245.
引证文献4
-
1陈小瑜,杨艾,吴红梅,杨茗,刘关键,董碧蓉.2型糖尿病肾脏疾病躯体危险因素的系统评价[J].中国循证医学杂志,2014,14(10):1201-1205. 被引量:3
-
2陈小瑜,杨艾,李婷,杨茗,刘关键,吴红梅.2型糖尿病患者并发肾脏疾病影响因素的Meta分析[J].中国全科医学,2015,18(22):2732-2736. 被引量:19
-
3潘恩春,缪丹丹,张芹,覃玉,孙中明,王闯,武鸣.2型糖尿病人群肾功能异常影响因素分析[J].中华疾病控制杂志,2017,21(9):913-916. 被引量:6
-
4王榕枫,邹玲梅,欧红芹.2型糖尿病患者尿白蛋白水平及其影响因素分析[J].安徽医学,2018,39(10):1218-1221. 被引量:2
二级引证文献30
-
1韩鹏,张铁山,贡欣扬,许树强.北京市社区2型糖尿病患者运动干预的影响因素研究[J].中国全科医学,2015,18(34):4248-4250. 被引量:11
-
2林秀雯.2型糖尿病患者发生慢性肾脏疾病的危险因素分析[J].临床医学,2016,36(3):9-11. 被引量:7
-
3肖政,刘莲花,汪成琼,楚亚林,胡世芸,邱隆敏,余昌胤.我国肺癌患者医院感染高危因素Meta分析[J].中国感染控制杂志,2016,15(8):561-569. 被引量:16
-
4杨志,张骥,唐立萍.糖尿病肾病患者血浆中VCAM-1、MIF、SFRP-5含量与肾功能损害的相关性研究[J].海南医学院学报,2016,22(24):2974-2977. 被引量:14
-
5刘利,刘晓玲,刘德线,吴静.糖尿病患者运动自我管理现状调查与分析[J].现代医药卫生,2017,33(8):1263-1265. 被引量:2
-
6叶尔肯.吐尔逊江.2型糖尿病患者合并糖尿病肾脏疾病的危险因素[J].世界最新医学信息文摘,2017,17(9):95-95.
-
7东珍,于秋红,谷晓宁.丹红注射液联合厄贝沙坦对糖尿病肾病患者氧化应激反应、肾功能损害的影响[J].海南医学院学报,2017,23(15):2052-2055. 被引量:8
-
8潘恩春,缪丹丹,张芹,覃玉,孙中明,王闯,武鸣.2型糖尿病人群肾功能异常影响因素分析[J].中华疾病控制杂志,2017,21(9):913-916. 被引量:6
-
9王存龙,龚菁菁,李小红,李银银,霍学云,路静,吕建祎,刘欣,郭萌,杜小燕,陈振文,李长龙.Mylpf基因在自发性糖尿病长爪沙鼠6种组织中的表达水平分析[J].实验动物科学,2017,34(5):1-5.
-
10金海英,张敏.VCAM-1、AOPP、HbA1c和FBG在二甲双胍治疗糖尿病肾病患者中的意义[J].标记免疫分析与临床,2018,25(1):50-53. 被引量:17
-
1黄胜利,陈宏慈,张华平.糖尿病微量白蛋白尿与胰岛素的早期使用疗效研究[J].中国当代医药,2014,21(28):66-68. 被引量:2
-
2张燕.百令胶囊对早期糖尿病肾病疗效观察[J].世界最新医学信息文摘,2013,13(15):215-215.
-
3罗丹,吴军,夏瑗瑜.伊贝沙坦治疗糖尿病肾病的临床研究[J].辽宁实用糖尿病杂志,2004,12(6):29-31.
-
4向良浩,张伟民,吴兴.高压氧联合葛根素治疗早期糖尿病肾病疗效观察[J].中国社区医师(医学专业),2011,13(19):36-36. 被引量:1
-
5李晓峰,张玉梅.福辛普利治疗早期糖尿病肾病疗效观察[J].社区医学杂志,2005,3(5):20-21.
-
6杨金奎.糖尿病患者应查微量白蛋白尿[J].糖尿病天地,2012(11):30-30.
-
7杨一芬,卿之驹,黄干.2型糖尿病肾病患者血清瘦素和脂联素检测的研究[J].实用预防医学,2007,14(5):1415-1417. 被引量:2
-
8董健.赖诺普利和氨氯地平对原发性高血压微量白蛋白尿的影响[J].临床合理用药杂志,2011,4(01X):8-9. 被引量:2
-
9陆绍强.依那普利、阿斯匹林治疗早期糖尿病肾病的临床疗效[J].广西医学,2004,26(2):186-188. 被引量:2
-
10朱德发,张莉,梁维龙,李道善.糖尿病合并高脂血症与血浆内皮素的关系[J].安徽医科大学学报,2000,35(2):139-140. 被引量:1